• About us
  • In brief
  • The Board of Directors
  • Management Team
  • Corporate Governance
  • Intellectual Properties
  • Partnerships
  • Environment & quality
  • Human Resources
  • Career
• Project portfolio
  • Project overview
  • Research areas
  • Development phases
  • Publications
• Contract Research
  • Autoradiography
  • Pharmacokinetics & Metabolism
  • Analytical chemistry
  • Disease models
• Investor info
  • Contacts
  • Press releases
  • Stock
  • Interim reports
  • Annual reports
  • Presentations
  • Ownership
  • Official documents
  • Calender
• Press & news
  • Press releases
  • Interim reports
  • Annual reports
  • Features
  • Image bank
  • Calender
  • Contacts
  • Reports
• Contact
  • Contacts
  • Visit us
  • FAQ

Investor info

• Contacts
• Press releases
• Stock
• Interim reports
• Annual reports
• Presentations
• Ownership
• Official documents
• Calender

Presentations

2010

Capital Markets Day in Stockholm, June 10, 2010

Keystone Symposia "Molecular and Cellular Biology of Immune Escape in Cancer" held in Keystone, Colorado, USA, February 7-12.

2009

UBS Global Life Sciences Conference held September 21-23, 2009 at the Grand Hyatt, Grand Central in New York City, US.

Rodman & Renshaw 11th Annual Healthcare Conference on Friday, September 11 2009 at the New York Palace Hotel in New York City, US.

10th Annual Congress of the European League against Rheumatism (EULAR), an international event for specialists in the field of rheumatology, held in Copenhagen June 10-13, 2009.

Active Biotech published data regarding a molecular target for the quinoline (Q) compounds in the scientific journal PLoS Biology, Volume 7, Issue 4, April 2009 (which is an open access journal and the full article is available at http://biology.plosjournals.org). Three of Active Biotech's projects (laquinimod, 57-57 and TASQ) belong to this chemical class of compounds.

2008

IBC's 6th Annual Antibody Therapeutics held in San Diego, US on December 9-11 2008

Advanced search